ANGIOGENESIS FOUNDATION INC (EIN 043266422) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1994

Legal Domicile

Principal Officer

WILLIAM W LI MD

Phone

6174012779

Tax Period

2024-04-01 to 2025-03-31

ANGIOGENESIS FOUNDATION INC, founded in 1994, is a community nonprofit in the Diseases & Disorders sector that reported $3.1M in total revenue in fiscal year 2024. Revenue surged 35% from the prior year, signaling strong growth momentum. The organization ran a surplus of $1.4M, a strong 46% operating margin.

Mission

TO IMPROVE GLOBAL HEALTH BY ADVANCING ANGIOGENESIS-BASED MEDICINE, DIET, AND LIFESTYLE. GOALS: 1) ADVANCE MODERN MEDICINE BY CHAMPIONING A NEW APPROACH TO CONQUERING DISEASE. 2) HELP PEOPLE LEAD LONGER HEALTHIER LIVES. 3) TRANSFORM THE WAY SOCIETY VIEWS HEALTH AND DISEASE THROUGH PUBLIC AWARENESS AND ADVOCACY, AND RESEARCH ON EVIDENCE-BASED DISEASE PREVENTION AND INTERVENTION.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $3,018,518

Program Service Revenue $11,500

Investment Income $66,304

Other Revenue $8,833

TOTAL REVENUE $3,105,155

Expense Breakdown

Grants Paid $0

Salaries & Benefits $965,954

Fundraising Expenses $95,780

Program Expenses $1,475,367

Other Expenses $718,433

TOTAL EXPENSES $1,684,387

Year-over-Year Comparison

	2024	2023	Change
Revenue	$3,105,155	$2,300,692	+0.3%
Expenses	$1,684,387	$1,214,030	+0.4%
Net Income	$1,420,768	$1,086,662	+0.3%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$617,360

Total Directors

$617,360

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
WILLIAM W LI MD	PRESIDENT, MEDICAL DIRECTOR	50.00	Officer Director	$279,168	$53,529	$332,697
VINCENT W LI MD MBA	COO, SCI DIRECTOR, TREASURER	50.00	Officer Director	$232,520	$52,143	$284,663
CHRISTOPHER J BONAR VMD	BOARD CHAIRMAN	5.00	Officer Director	$0	$0	$0
SHAWNA C LI DVM	BOARD SECRETARY	1.00	Officer Director	$0	$0	$0
NICOLE K FIRESTONE MBA	DIRECTOR	1.00	Director	$0	$0	$0
LOUIS C HOOK JR MBA	DIRECTOR	1.00	Director	$0	$0	$0
DAVID EVANS HON DMUS	DIRECTOR	1.00	Director	$0	$0	$0
DANIEL C RUTZ MPH	DIRECTOR	1.00	Director	$0	$0	$0
FRANK BURROWS MBA	DIRECTOR	1.00	Director	$0	$0	$0
BRIAN CAREY	DIRECTOR	1.00	Director	$0	$0	$0
RACHAEL RAY	DIRECTOR	1.00	Director	$0	$0	$0
ROBIN L SMITH MD MBA	DIRECTOR	1.00	Director	$0	$0	$0
ANDREW C VON ESCHENBACH MD	DIRECTOR	1.00	Director	$0	$0	$0
MARIA AUFIERO	DIRECTOR OF OPERATIONS	50.00	Highest	$165,000	$4,950	$169,950

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$3,105,155	$1,684,387	$2,773,217	$1,420,768
2024	$2,300,692	$1,214,030	$1,344,088	$1,086,662
2023	$959,378	$1,126,554	$335,627	$-167,176
2022	$1,243,407	$1,104,890	$359,298	$138,517
2021	$642,957	$1,072,174	$372,545	$-429,217
2020	$1,086,330	$1,650,107	$714,669	$-563,777
2019	$2,456,629	$1,966,150	$1,232,819	$490,479
2018	$2,220,956	$2,107,872	$890,845	$113,084

ANGIOGENESIS FOUNDATION INC